サマリー

医薬品有効成分の世界市場 2024-2028
医薬品有効成分市場は2023〜2028年に864億7000万米ドル成長し、予測期間中のCAGRは6.73%で加速すると予測される。当レポートでは、医薬品有効成分市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場を牽引しているのは、発展途上国におけるapi製造シナリオの進化、タイプII医薬品マスターファイル（DMF）の増加、コアコンピタンスに集中するニーズの高まりです。
Technavioの原薬市場は以下のように区分される：
製造タイプ別
- キャプティブAPI
- 受託API
タイプ別
- 革新的API
- 汎用API
地域別
- アジア
- 北米
- ヨーロッパ
- その他の地域（ROW）
本調査では、原薬製造におけるパラダイムシフトが、今後数年間の原薬市場の成長を牽引する主要な要因の一つであるとしている。また、特許行使の増加や老人人口の増加は、市場の大きな需要につながる。
本レポートでは、医薬品原薬市場について以下の分野をカバーしています：
- 医薬品有効成分市場のサイジング
- 原薬市場予測
- 医薬品有効成分市場の産業分析
堅牢なベンダー分析は、クライアントが市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Amneal Pharmaceuticals Inc.、Apotex Inc.、Aurobindo Pharma Ltd.、Cadila Pharmaceuticals Ltd.、Cambrex Corp、Cambrex Corp.、Cipla Ltd.、Dr Reddys Laboratories Ltd.、GlaxoSmithKline Plc.、Indena S.p.A.、INTERNATIONAL CHEMICAL INVESTORS S.E.、Koninklijke DSM NV、Lupin Ltd.、Novartis AG、Pfizer Inc.、Sanofi SA、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Thermo Fisher Scientific Inc.、Viatris Inc.などである。また、原薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Manufacturing Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global active pharmaceutical ingredients market (API) 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global active pharmaceutical ingredients market (API) 2018 - 2022 ($ billion)
o 4.2 Manufacturing Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Manufacturing Type Segment 2018 - 2022 ($ billion)
o 4.3 Type Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Manufacturing Type
o 6.1 Market segments
o Exhibit 30: Chart on Manufacturing Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Manufacturing Type - Market share 2023-2028 (%)
o 6.2 Comparison by Manufacturing Type
o Exhibit 32: Chart on Comparison by Manufacturing Type
o Exhibit 33: Data Table on Comparison by Manufacturing Type
o 6.3 Captive APIs - Market size and forecast 2023-2028
o Exhibit 34: Chart on Captive APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Captive APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Captive APIs - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Captive APIs - Year-over-year growth 2023-2028 (%)
o 6.4 Contract APIs - Market size and forecast 2023-2028
o Exhibit 38: Chart on Contract APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Contract APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Contract APIs - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Contract APIs - Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Manufacturing Type
o Exhibit 42: Market opportunity by Manufacturing Type ($ billion)
o Exhibit 43: Data Table on Market opportunity by Manufacturing Type ($ billion)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 44: Chart on Type - Market share 2023-2028 (%)
o Exhibit 45: Data Table on Type - Market share 2023-2028 (%)
o 7.2 Comparison by Type
o Exhibit 46: Chart on Comparison by Type
o Exhibit 47: Data Table on Comparison by Type
o 7.3 Innovative APIs - Market size and forecast 2023-2028
o Exhibit 48: Chart on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Innovative APIs - Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Innovative APIs - Year-over-year growth 2023-2028 (%)
o 7.4 Generic APIs - Market size and forecast 2023-2028
o Exhibit 52: Chart on Generic APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Generic APIs - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Generic APIs - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Generic APIs - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Type
o Exhibit 56: Market opportunity by Type ($ billion)
o Exhibit 57: Data Table on Market opportunity by Type ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2023-2028
o Exhibit 63: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.4 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.5 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 China - Market size and forecast 2023-2028
o Exhibit 79: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.8 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.9 India - Market size and forecast 2023-2028
o Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%)
o 9.10 Japan - Market size and forecast 2023-2028
o Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.11 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 107: AbbVie Inc. - Overview
o Exhibit 108: AbbVie Inc. - Product / Service
o Exhibit 109: AbbVie Inc. - Key news
o Exhibit 110: AbbVie Inc. - Key offerings
o 12.4 Amneal Pharmaceuticals Inc.
o Exhibit 111: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 112: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 113: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 114: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 115: Amneal Pharmaceuticals Inc. - Segment focus
o 12.5 Aurobindo Pharma Ltd.
o Exhibit 116: Aurobindo Pharma Ltd. - Overview
o Exhibit 117: Aurobindo Pharma Ltd. - Product / Service
o Exhibit 118: Aurobindo Pharma Ltd. - Key offerings
o 12.6 Cadila Pharmaceuticals Ltd.
o Exhibit 119: Cadila Pharmaceuticals Ltd. - Overview
o Exhibit 120: Cadila Pharmaceuticals Ltd. - Product / Service
o Exhibit 121: Cadila Pharmaceuticals Ltd. - Key offerings
o 12.7 Cipla Ltd.
o Exhibit 122: Cipla Ltd. - Overview
o Exhibit 123: Cipla Ltd. - Business segments
o Exhibit 124: Cipla Ltd. - Key news
o Exhibit 125: Cipla Ltd. - Key offerings
o Exhibit 126: Cipla Ltd. - Segment focus
o 12.8 Dr Reddys Laboratories Ltd.
o Exhibit 127: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 128: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 129: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 130: Dr Reddys Laboratories Ltd. - Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 131: GlaxoSmithKline Plc - Overview
o Exhibit 132: GlaxoSmithKline Plc - Business segments
o Exhibit 133: GlaxoSmithKline Plc - Key news
o Exhibit 134: GlaxoSmithKline Plc - Key offerings
o Exhibit 135: GlaxoSmithKline Plc - Segment focus
o 12.10 Koninklijke DSM NV
o Exhibit 136: Koninklijke DSM NV - Overview
o Exhibit 137: Koninklijke DSM NV - Business segments
o Exhibit 138: Koninklijke DSM NV - Key news
o Exhibit 139: Koninklijke DSM NV - Key offerings
o Exhibit 140: Koninklijke DSM NV - Segment focus
o 12.11 Lupin Ltd.
o Exhibit 141: Lupin Ltd. - Overview
o Exhibit 142: Lupin Ltd. - Product / Service
o Exhibit 143: Lupin Ltd. - Key news
o Exhibit 144: Lupin Ltd. - Key offerings
o 12.12 Novartis AG
o Exhibit 145: Novartis AG - Overview
o Exhibit 146: Novartis AG - Business segments
o Exhibit 147: Novartis AG - Key offerings
o Exhibit 148: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 149: Pfizer Inc. - Overview
o Exhibit 150: Pfizer Inc. - Product / Service
o Exhibit 151: Pfizer Inc. - Key news
o Exhibit 152: Pfizer Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 153: Sanofi SA - Overview
o Exhibit 154: Sanofi SA - Business segments
o Exhibit 155: Sanofi SA - Key news
o Exhibit 156: Sanofi SA - Key offerings
o Exhibit 157: Sanofi SA - Segment focus
o 12.15 Sun Pharmaceutical Industries Ltd.
o Exhibit 158: Sun Pharmaceutical Industries Ltd. - Overview
o Exhibit 159: Sun Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 160: Sun Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 161: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 162: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 163: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 164: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 165: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Viatris Inc.
o Exhibit 166: Viatris Inc. - Overview
o Exhibit 167: Viatris Inc. - Business segments
o Exhibit 168: Viatris Inc. - Key news
o Exhibit 169: Viatris Inc. - Key offerings
o Exhibit 170: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Manufacturing Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global active pharmaceutical ingredients market (API) 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Manufacturing Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Manufacturing Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Manufacturing Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Manufacturing Type
Exhibits33: Data Table on Comparison by Manufacturing Type
Exhibits34: Chart on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Captive APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Captive APIs - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Captive APIs - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Contract APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Contract APIs - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Contract APIs - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Manufacturing Type ($ billion)
Exhibits43: Data Table on Market opportunity by Manufacturing Type ($ billion)
Exhibits44: Chart on Type - Market share 2023-2028 (%)
Exhibits45: Data Table on Type - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Innovative APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Innovative APIs - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Innovative APIs - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Generic APIs - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Generic APIs - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Generic APIs - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Type ($ billion)
Exhibits57: Data Table on Market opportunity by Type ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amneal Pharmaceuticals Inc. - Overview
Exhibits112: Amneal Pharmaceuticals Inc. - Business segments
Exhibits113: Amneal Pharmaceuticals Inc. - Key news
Exhibits114: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits115: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits116: Aurobindo Pharma Ltd. - Overview
Exhibits117: Aurobindo Pharma Ltd. - Product / Service
Exhibits118: Aurobindo Pharma Ltd. - Key offerings
Exhibits119: Cadila Pharmaceuticals Ltd. - Overview
Exhibits120: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits121: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits122: Cipla Ltd. - Overview
Exhibits123: Cipla Ltd. - Business segments
Exhibits124: Cipla Ltd. - Key news
Exhibits125: Cipla Ltd. - Key offerings
Exhibits126: Cipla Ltd. - Segment focus
Exhibits127: Dr Reddys Laboratories Ltd. - Overview
Exhibits128: Dr Reddys Laboratories Ltd. - Business segments
Exhibits129: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits130: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits131: GlaxoSmithKline Plc - Overview
Exhibits132: GlaxoSmithKline Plc - Business segments
Exhibits133: GlaxoSmithKline Plc - Key news
Exhibits134: GlaxoSmithKline Plc - Key offerings
Exhibits135: GlaxoSmithKline Plc - Segment focus
Exhibits136: Koninklijke DSM NV - Overview
Exhibits137: Koninklijke DSM NV - Business segments
Exhibits138: Koninklijke DSM NV - Key news
Exhibits139: Koninklijke DSM NV - Key offerings
Exhibits140: Koninklijke DSM NV - Segment focus
Exhibits141: Lupin Ltd. - Overview
Exhibits142: Lupin Ltd. - Product / Service
Exhibits143: Lupin Ltd. - Key news
Exhibits144: Lupin Ltd. - Key offerings
Exhibits145: Novartis AG - Overview
Exhibits146: Novartis AG - Business segments
Exhibits147: Novartis AG - Key offerings
Exhibits148: Novartis AG - Segment focus
Exhibits149: Pfizer Inc. - Overview
Exhibits150: Pfizer Inc. - Product / Service
Exhibits151: Pfizer Inc. - Key news
Exhibits152: Pfizer Inc. - Key offerings
Exhibits153: Sanofi SA - Overview
Exhibits154: Sanofi SA - Business segments
Exhibits155: Sanofi SA - Key news
Exhibits156: Sanofi SA - Key offerings
Exhibits157: Sanofi SA - Segment focus
Exhibits158: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits159: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits160: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits161: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits162: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits163: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits164: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits165: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits166: Viatris Inc. - Overview
Exhibits167: Viatris Inc. - Business segments
Exhibits168: Viatris Inc. - Key news
Exhibits169: Viatris Inc. - Key offerings
Exhibits170: Viatris Inc. - Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations